Logo Internet-AI colonne_top.png, 439B

Members



content_top.png, 479B

> Top story

PARTNERSHIP BETWEEN CHEM-X-INFINITY AND OXELTIS

PARTNERSHIP BETWEEN CHEM-X-INFINITY AND OXELTIS

PARTNERSHIP BETWEEN CHEM-X-INFINITY AND OXELTIS 02/01/2012

CHEM-X-INFINITY partnered with OXELTIS to design and produce focused libraries based on nucleosides. The compounds involve combinations of new sugars and bases and will have applications in the antiviral field and for some GPCRs.

page(s)
CHEM-X-INFINITY AND ORIBASE PHARMA RELEASE A KINASE FOCUSED LIBRARY 23/12/2013

CHEM-X-INFINITY is pleased to announce a new library focused on kinases. The original six scaffold subfamilies designed in collaboration with Oribase Pharma are known to display activities against several targets with applications in oncology.

PARTNERSHIP BETWEEN CHEM-X-INFINITY AND OXELTIS 02/01/2012

CHEM-X-INFINITY partnered with OXELTIS to design and produce focused libraries based on nucleosides. The compounds involve combinations of new sugars and bases and will have applications in the antiviral field and for some GPCRs.

PARTNERSHIP BETWEEN CHEM-X-INFINITY AND XANCHEM 27/09/2011

CHEM-X-INFINITY partnered with XANCHEM to produce libraries around original scaffolds. The compounds will be of particular interest in the oncology field.

PARTNERSHIP BETWEEN CHEM-X-INFINITY AND ORIBASE PHARMA 20/07/2011

CHEM-X-INFINITY partnered with ORIBASE PHARMA to offer kinase focused libraries. The compounds are built around several small aza-heterocycles underused in combinatorial libraries and will have applications in the oncology field.

CHEM-X-INFINITY WILL ATTEND THE 18TH MOLECULAR MEDICINE TRI-CONFERENCE 11/01/2011

CHEM-X-INFINITY will attend the 18th Molecular Medicine Tri-Conference on February 23rd-25th, 2011 in San Francisco, CA.

REPORT OF THE SCT ANNUAL WORKSHOP IN MEDICINAL CHEMISTRY 10/12/2010

The SCT Annual Workshop in Medicinal Chemistry was held the 7th of December in Paris at the Faculté de Médecine Cochin Port-Royal in collaboration with GFPP. Please read in this news our feeling about the event.

PARTNERSHIP BETWEEN CHEM-X-INFINITY AND DIVERCHIM 19/11/2010

CHEM-X-INFINITY partnered with DIVERCHIM to design and produce original libraries from synthetic analogues of natural compounds. The compounds will be of particular interest in the oncology field.

CHEM-X-INFINITY ATTENDED THE XXIst INTERNATIONAL SYMPOSIUM OF MEDICINAL CHEMISTRY 22/09/2010

CHEM-X-INFINITY attended the 21st International Symposium of Medicinal Chemistry on September 5th-9th, 2010, in Brussels, Belgium. Please read in this news our feeling about the event.

CHEM-X-INFINITY AND PROVENCE TECHNOLOGIES RELEASE AN AZAINDOLE LIBRARY 14/05/2010

CHEM-X-INFINITY is pleased to announce a new library focused on kinases, DNA processing enzymes and GPCRs. The original azaindole scaffold could be useful for the identification of new potent series. The library was co-designed with Provence Technologies which is a company specialized in the synthesis of azaindoles.

CHEM-X-INFINITY RELEASES A PEPTIDE SURROGATE LIBRARY 17/02/2010

CHEM-X-INFINITY is pleased to announce a new library focused on proteases. Two versatile linkers have been used to synthesize compounds able to interact with serine and cysteine residues of proteins. The compounds could also have applications in GPCRs and antibiotics.

page(s)
footer_top.png, 537B